Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
Sales | 1,122,057 | 1,116,898 | 1,033,744 | 950,294 | 914,738 |
Cost of Goods | 504,672 | 499,146 | 454,029 | 409,484 | 392,231 |
Gross Profit | 617,385 | 617,752 | 579,715 | 540,810 | 522,507 |
Operating Expenses | 342,790 | 317,227 | 299,550 | 265,555 | 267,341 |
Operating Income | 275,267 | 300,671 | 280,194 | 275,739 | 255,397 |
Interest Expense | 14,943 | 14,964 | 10,338 | 7,134 | 5,542 |
Other Income | 16,478 | 3,671 | 3,835 | -6,812 | -11,765 |
Pre-tax Income | 276,802 | 289,378 | 273,691 | 261,793 | 238,090 |
Income Tax | 47,138 | 56,878 | 48,777 | 51,315 | 43,029 |
Net Income Continuous | 229,664 | 232,500 | 224,914 | 210,478 | 195,061 |
Net Income | $229,664 | $232,500 | $224,914 | $210,478 | $195,061 |
EPS Basic Total Ops | 1.57 | 1.58 | 1.53 | 1.44 | 1.34 |
EPS Basic Continuous Ops | 1.56 | 1.58 | 1.53 | 1.44 | 1.33 |
EPS Diluted Total Ops | 1.55 | 1.58 | 1.53 | 1.43 | 1.32 |
EPS Diluted Continuous Ops | 1.55 | 1.58 | 1.53 | 1.43 | 1.32 |
EPS Diluted Before Non-Recurring Items | 1.60 | 1.68 | 1.66 | N/A | N/A |
EBITDA(a) | $330,466 | $353,461 | $325,733 | $319,773 | $300,404 |